Karyopharm Therapeutics Inc.

Q3 2022 13F Holders

Symbol
KPTI
CUSIP
48576U106
Type
Equity
Class
COM
Num filers
149
Total reported value, excl. options
$365 M
Manager Report Date Value ($000) Shares Option Type